Cover Image
Market Research Report

Global CNS Therapeutics Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 797240
Published Content info 109 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global CNS Therapeutics Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 109 Pages
Description

Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer's) or voluntary motion (in movement disorders).

Mental health segment accounted for the largest market share in 2016. It is expected to retain its dominance over the forecast period owing to developing therapeutic options for mental diseases such as personality disorders and binge eating disorders. This segment is followed by degenerative disorders segment. There is growing awareness regarding neurodegenerative diseases owing to increase in initiatives by government and nongovernment organizations, such as Alzheimer's and Related Disorders Society of India. These organizations conduct awareness campaigns and conferences, such as Asia Pacific Conference of ADI at New Delhi and Kerala State Initiative on Dementia, which encourage the adoption of treatment for degenerative and mental disorders.

In 2018, the global CNS Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global CNS Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CNS Therapeutics development in United States, Europe and China.

The key players covered in this study

  • Pfizer
  • Janssen Pharmaceuticals
  • Allergan
  • Lundbeck
  • Teva
  • Camber Pharmaceuticals
  • Zhejiang Haisen Pharmaceutical
  • Jewim Pharmaceutical
  • Cipla
  • Merck Sharp & Dohme Corp.
  • Eli Lilly
  • GlaxoSmithKline
  • Novartis
  • LUPIN
  • ZYDUS PHARMS
  • Biogen
  • Otsuka Pharmaceutical
  • Astra Zeneca
  • Shire

Market segment by Type, the product can be split into

  • Neurodegenerative Diseases
  • Mood Disorders
  • Schizophrenia
  • Autism
  • Depression

Market segment by Application, split into

  • Hospital Use
  • Clinic Use
  • Household
  • Other

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global CNS Therapeutics status, future forecast, growth opportunity, key market and key players.
  • To present the CNS Therapeutics development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of CNS Therapeutics are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global CNS Therapeutics Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Neurodegenerative Diseases
    • 1.4.3 Mood Disorders
    • 1.4.4 Schizophrenia
    • 1.4.5 Autism
    • 1.4.6 Depression
  • 1.5 Market by Application
    • 1.5.1 Global CNS Therapeutics Market Share by Application (2014-2025)
    • 1.5.2 Hospital Use
    • 1.5.3 Clinic Use
    • 1.5.4 Household
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 CNS Therapeutics Market Size
  • 2.2 CNS Therapeutics Growth Trends by Regions
    • 2.2.1 CNS Therapeutics Market Size by Regions (2014-2025)
    • 2.2.2 CNS Therapeutics Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 CNS Therapeutics Market Size by Manufacturers
    • 3.1.1 Global CNS Therapeutics Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global CNS Therapeutics Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global CNS Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2 CNS Therapeutics Key Players Head office and Area Served
  • 3.3 Key Players CNS Therapeutics Product/Solution/Service
  • 3.4 Date of Enter into CNS Therapeutics Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global CNS Therapeutics Market Size by Type (2014-2019)
  • 4.2 Global CNS Therapeutics Market Size by Application (2014-2019)

5 United States

  • 5.1 United States CNS Therapeutics Market Size (2014-2019)
  • 5.2 CNS Therapeutics Key Players in United States
  • 5.3 United States CNS Therapeutics Market Size by Type
  • 5.4 United States CNS Therapeutics Market Size by Application

6 Europe

  • 6.1 Europe CNS Therapeutics Market Size (2014-2019)
  • 6.2 CNS Therapeutics Key Players in Europe
  • 6.3 Europe CNS Therapeutics Market Size by Type
  • 6.4 Europe CNS Therapeutics Market Size by Application

7 China

  • 7.1 China CNS Therapeutics Market Size (2014-2019)
  • 7.2 CNS Therapeutics Key Players in China
  • 7.3 China CNS Therapeutics Market Size by Type
  • 7.4 China CNS Therapeutics Market Size by Application

8 Japan

  • 8.1 Japan CNS Therapeutics Market Size (2014-2019)
  • 8.2 CNS Therapeutics Key Players in Japan
  • 8.3 Japan CNS Therapeutics Market Size by Type
  • 8.4 Japan CNS Therapeutics Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia CNS Therapeutics Market Size (2014-2019)
  • 9.2 CNS Therapeutics Key Players in Southeast Asia
  • 9.3 Southeast Asia CNS Therapeutics Market Size by Type
  • 9.4 Southeast Asia CNS Therapeutics Market Size by Application

10 India

  • 10.1 India CNS Therapeutics Market Size (2014-2019)
  • 10.2 CNS Therapeutics Key Players in India
  • 10.3 India CNS Therapeutics Market Size by Type
  • 10.4 India CNS Therapeutics Market Size by Application

11 Central & South America

  • 11.1 Central & South America CNS Therapeutics Market Size (2014-2019)
  • 11.2 CNS Therapeutics Key Players in Central & South America
  • 11.3 Central & South America CNS Therapeutics Market Size by Type
  • 11.4 Central & South America CNS Therapeutics Market Size by Application

12 International Players Profiles

  • 12.1 Pfizer
    • 12.1.1 Pfizer Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 CNS Therapeutics Introduction
    • 12.1.4 Pfizer Revenue in CNS Therapeutics Business (2014-2019)
    • 12.1.5 Pfizer Recent Development
  • 12.2 Janssen Pharmaceuticals
    • 12.2.1 Janssen Pharmaceuticals Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 CNS Therapeutics Introduction
    • 12.2.4 Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2014-2019)
    • 12.2.5 Janssen Pharmaceuticals Recent Development
  • 12.3 Allergan
    • 12.3.1 Allergan Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 CNS Therapeutics Introduction
    • 12.3.4 Allergan Revenue in CNS Therapeutics Business (2014-2019)
    • 12.3.5 Allergan Recent Development
  • 12.4 Lundbeck
    • 12.4.1 Lundbeck Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 CNS Therapeutics Introduction
    • 12.4.4 Lundbeck Revenue in CNS Therapeutics Business (2014-2019)
    • 12.4.5 Lundbeck Recent Development
  • 12.5 Teva
    • 12.5.1 Teva Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 CNS Therapeutics Introduction
    • 12.5.4 Teva Revenue in CNS Therapeutics Business (2014-2019)
    • 12.5.5 Teva Recent Development
  • 12.6 Camber Pharmaceuticals
    • 12.6.1 Camber Pharmaceuticals Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 CNS Therapeutics Introduction
    • 12.6.4 Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2014-2019)
    • 12.6.5 Camber Pharmaceuticals Recent Development
  • 12.7 Zhejiang Haisen Pharmaceutical
    • 12.7.1 Zhejiang Haisen Pharmaceutical Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 CNS Therapeutics Introduction
    • 12.7.4 Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2014-2019)
    • 12.7.5 Zhejiang Haisen Pharmaceutical Recent Development
  • 12.8 Jewim Pharmaceutical
    • 12.8.1 Jewim Pharmaceutical Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 CNS Therapeutics Introduction
    • 12.8.4 Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2014-2019)
    • 12.8.5 Jewim Pharmaceutical Recent Development
  • 12.9 Cipla
    • 12.9.1 Cipla Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 CNS Therapeutics Introduction
    • 12.9.4 Cipla Revenue in CNS Therapeutics Business (2014-2019)
    • 12.9.5 Cipla Recent Development
  • 12.10 Merck Sharp & Dohme Corp.
    • 12.10.1 Merck Sharp & Dohme Corp. Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 CNS Therapeutics Introduction
    • 12.10.4 Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2014-2019)
    • 12.10.5 Merck Sharp & Dohme Corp. Recent Development
  • 12.11 Eli Lilly
  • 12.12 GlaxoSmithKline
  • 12.13 Novartis
  • 12.14 LUPIN
  • 12.15 ZYDUS PHARMS
  • 12.16 Biogen
  • 12.17 Otsuka Pharmaceutical
  • 12.18 Astra Zeneca
  • 12.19 Shire

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table CNS Therapeutics Key Market Segments
  • Table Key Players CNS Therapeutics Covered
  • Table Global CNS Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global CNS Therapeutics Market Size Market Share by Type 2014-2025
  • Figure Neurodegenerative Diseases Figures
  • Table Key Players of Neurodegenerative Diseases
  • Figure Mood Disorders Figures
  • Table Key Players of Mood Disorders
  • Figure Schizophrenia Figures
  • Table Key Players of Schizophrenia
  • Figure Autism Figures
  • Table Key Players of Autism
  • Figure Depression Figures
  • Table Key Players of Depression
  • Table Global CNS Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Hospital Use Case Studies
  • Figure Clinic Use Case Studies
  • Figure Household Case Studies
  • Figure Other Case Studies
  • Figure CNS Therapeutics Report Years Considered
  • Table Global CNS Therapeutics Market Size 2014-2025 (Million US$)
  • Figure Global CNS Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global CNS Therapeutics Market Size by Regions 2014-2025 (Million US$)
  • Table Global CNS Therapeutics Market Size by Regions 2014-2019 (Million US$)
  • Table Global CNS Therapeutics Market Share by Regions 2014-2019
  • Figure Global CNS Therapeutics Market Share by Regions 2014-2019
  • Figure Global CNS Therapeutics Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global CNS Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global CNS Therapeutics Market Share by Manufacturers (2014-2019)
  • Figure Global CNS Therapeutics Market Share by Manufacturers in 2018
  • Table Global CNS Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players CNS Therapeutics Product/Solution/Service
  • Table Date of Enter into CNS Therapeutics Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global CNS Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Global CNS Therapeutics Market Size Share by Type (2014-2019)
  • Figure Global CNS Therapeutics Market Size Market Share by Type (2014-2019)
  • Table Global CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Global CNS Therapeutics Market Size Share by Application (2014-2019)
  • Figure Global CNS Therapeutics Market Size Market Share by Application (2014-2019)
  • Figure Global CNS Therapeutics Revenue Market Share by Application in 2018
  • Figure United States CNS Therapeutics Market Size 2014-2019 (Million US$)
  • Table United States Key Players CNS Therapeutics Revenue (2018-2019) (Million US$)
  • Table United States Key Players CNS Therapeutics Market Share (2018-2019)
  • Table United States CNS Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table United States CNS Therapeutics Market Share by Type (2014-2019)
  • Table United States CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table United States CNS Therapeutics Market Share by Application (2014-2019)
  • Figure Europe CNS Therapeutics Market Size 2014-2019 (Million US$)
  • Table Europe Key Players CNS Therapeutics Revenue (2018-2019) (Million US$)
  • Table Europe Key Players CNS Therapeutics Market Share (2018-2019)
  • Table Europe CNS Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Europe CNS Therapeutics Market Share by Type (2014-2019)
  • Table Europe CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Europe CNS Therapeutics Market Share by Application (2014-2019)
  • Figure China CNS Therapeutics Market Size 2014-2019 (Million US$)
  • Table China Key Players CNS Therapeutics Revenue (2018-2019) (Million US$)
  • Table China Key Players CNS Therapeutics Market Share (2018-2019)
  • Table China CNS Therapeutics Market Size by Type (2014-20189) (Million US$)
  • Table China CNS Therapeutics Market Share by Type (2014-2019)
  • Table China CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table China CNS Therapeutics Market Share by Application (2014-2019)
  • Figure Japan CNS Therapeutics Market Size 2014-2019 (Million US$)
  • Table Japan Key Players CNS Therapeutics Revenue (2018-2019) (Million US$)
  • Table Japan Key Players CNS Therapeutics Market Share (2018-2019)
  • Table Japan CNS Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Japan CNS Therapeutics Market Share by Type (2014-2019)
  • Table Japan CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Japan CNS Therapeutics Market Share by Application (2014-2019)
  • Figure Southeast Asia CNS Therapeutics Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players CNS Therapeutics Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players CNS Therapeutics Market Share (2018-2019)
  • Table Southeast Asia CNS Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia CNS Therapeutics Market Share by Type (2014-2019)
  • Table Southeast Asia CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia CNS Therapeutics Market Share by Application (2014-2019)
  • Figure India CNS Therapeutics Market Size 2014-2019 (Million US$)
  • Table India Key Players CNS Therapeutics Revenue (2018-2019) (Million US$)
  • Table India Key Players CNS Therapeutics Market Share (2018-2019)
  • Table India CNS Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table India CNS Therapeutics Market Share by Type (2014-2019)
  • Table India CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table India CNS Therapeutics Market Share by Application (2014-2019)
  • Figure Central & South America CNS Therapeutics Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players CNS Therapeutics Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players CNS Therapeutics Market Share (2018-2019)
  • Table Central & South America CNS Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America CNS Therapeutics Market Share by Type (2014-2019)
  • Table Central & South America CNS Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America CNS Therapeutics Market Share by Application (2014-2019)
  • Table Pfizer Company Details
  • Table Pfizer Revenue in CNS Therapeutics Business (2014-2019) (Million US$)
  • Figure Pfizer Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Pfizer Recent Development
  • Table Janssen Pharmaceuticals Company Details
  • Table Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Janssen Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Janssen Pharmaceuticals Recent Development
  • Table Allergan Company Details
  • Table Allergan Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Allergan Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Allergan Recent Development
  • Table Lundbeck Company Details
  • Table Lundbeck Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Lundbeck Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Lundbeck Recent Development
  • Table Teva Company Details
  • Table Teva Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Teva Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Teva Recent Development
  • Table Camber Pharmaceuticals Company Details
  • Table Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Camber Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Camber Pharmaceuticals Recent Development
  • Table Zhejiang Haisen Pharmaceutical Company Details
  • Table Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Zhejiang Haisen Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Zhejiang Haisen Pharmaceutical Recent Development
  • Table Jewim Pharmaceutical Company Details
  • Table Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Jewim Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Jewim Pharmaceutical Recent Development
  • Table Cipla Company Details
  • Table Cipla Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Cipla Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Cipla Recent Development
  • Table Merck Sharp & Dohme Corp. Company Details
  • Table Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2014-2019)(Million US$)
  • Figure Merck Sharp & Dohme Corp. Revenue Growth Rate in CNS Therapeutics Business (2014-2019)
  • Table Merck Sharp & Dohme Corp. Recent Development
  • Table Eli Lilly Company Details
  • Table GlaxoSmithKline Company Details
  • Table Novartis Company Details
  • Table LUPIN Company Details
  • Table ZYDUS PHARMS Company Details
  • Table Biogen Company Details
  • Table Otsuka Pharmaceutical Company Details
  • Table Astra Zeneca Company Details
  • Table Shire Company Details
  • Table Global CNS Therapeutics Market Size by Regions (Million US$) 2019-2025
  • Figure Global CNS Therapeutics Market Size Share by Regions (2019-2025)
  • Figure Global CNS Therapeutics Market Size Share by Regions in 2025
  • Figure United States CNS Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe CNS Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure China CNS Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan CNS Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia CNS Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure India CNS Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America CNS Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Table Global CNS Therapeutics Market Size by Product (2019-2025) (Million US$)
  • Figure Global CNS Therapeutics Market Size by Product (2019-2025)
  • Figure Global CNS Therapeutics Market Size by Product in 2025
  • Table Global CNS Therapeutics Market Size by Application (2019-2025) (Million US$)
  • Figure Global CNS Therapeutics Market Size by Application (2019-2025)
  • Figure Global CNS Therapeutics Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top